George Owen

Growth Director at ONI

George Owen is currently the Growth Director at ONI. Prior to this, they were a Senior Associate - Life Sciences, Healthcare & Digital Health at True Search from October 2020 to January 2022. George was also a Senior Executive Researcher at PIR International from June 2019 to October 2020, and a Researcher, Life Sciences at Amrop from September 2018 to June 2019.

George Owen has a Masters in Infection and Immunity from September 2017 to September 2018. George's primary interest is based around the epidemiology of infectious diseases in developing countries and how computational methods can be applied to track outbreaks and consequential spread, serving to identify unusual trends in outbreak resurgence/regression. These trends can lend themselves to understanding unknown existing mechanisms by which we are able to defend ourselves from infectious diseases, presenting alternative treatment pathways.

George Owen has a Master of Science in Infection and Immunity from UCL and a Bachelor's Degree in Microbiology, General from Cardiff University / Prifysgol Caerdydd.

Their manager is Sophia Mowla, Chief Growth Officer. George Owen works with Camille Muletier - Technical Recruiter, Olivia Dueser - Growth Director.

Location

Oxford, United Kingdom

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


ONI

7 followers

ONI is a pioneer of next generation super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal. The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard. ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.


Industries

Employees

201-500

Links